Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pulse Oximeter Market Overview (2022 to 2032)

A newly-released Pulse Oximeter Market analysis report by Future Market Insights shows that global sales of the Pulse Oximeter Market in 2021 were held at US$ 2.3 billion. With a 7.6% CAGR from 2022 to 2032, the market is projected to reach a valuation of US$ 5.1 billion by 2032. The Handheld Pulse Oximeter Market type is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 8.4% from 2022 to 2032.

Attributes Details
Global Pulse Oximeter Pulse Oximeter Market Size (2022) US$ 2.5 billion
Global Pulse Oximeter Pulse Oximeter Market Size (2032) US$ 5.1 billion
Global Pulse Oximeter Pulse Oximeter Market CAGR (2022 to 2032) 7.6%
The USA Pulse Oximeter Pulse Oximeter Market CAGR (2022 to 2032) 7.6%
Key Companies Covered
  • Medtronic plc
  • Carefusion Corp
  • GE Healthcare
  • Philips Healthcare
  • Masimo
  • CAS Medical Systems, Inc
  • Opto Circuits India Ltd.
  • Nonin Medical, Inc.
  • Meditech Equipment Co.
  • Welch Allyn

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Pulse Oximeter Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Global Pulse Oximeter Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pulse Oximeter Market increased at around 7.4% CAGR.

The key revenue drivers which affected the Pulse Oximeter Market are the prevalence of chronic diseases and the advent of the coronavirus enhanced the market's demand for pulse oximeters. The rising prevalence of specific disorders like asthma, hyperlipidemia, high blood pressure, diabetes, ischemic conditions, cardiac arrhythmia, sleep apnea, and COPD is expected to further drive the market. The WHO estimates that 64 million people globally suffer from COPD and that 90% of COPD deaths take place in low- and middle-income nations.

The rise in chronic diseases such as cancer (currently there are more than 200 types of cancer in the world), diabetes, heart disease, and other diseases, is expected to drive the adoption of the pulse oximeter market. Globally, chronic illness and disease are on the rise. The growing number of elderly individuals, as well as changes in social behavior, are contributing to the rise in these common and chronic health issues.

The middle-class population is expanding, and as the city expands, people’s lives expand at the same rate. Obesity and disorders like diabetes are becoming more likely as a result. Chronic disease prevalence climbed by 57% by 2020, according to the World Health Organization. Chronic sickness has resulted in an increase in demand for Pulse Oximeter Market.

What Factors Are Propelling Pulse Oximeter Market Demand?

The key factor which is propelling the market is the rising numbers of the geriatric population which eventually increases the chronic disease numbers. The rising prevalence of the target disorders and growing awareness of the uses of pulse oximeters in Covid-19 management are anticipated to fuel market expansion.

As a result of Covid-19, respiratory monitoring is currently receiving more attention, and self-monitoring is being replaced by pulse oximeters. Additionally, the rising demand for patient monitoring in non-hospital settings due to an increase in surgical procedures and potential opportunities for site care is anticipated to offer market players significant growth opportunities over the course of the forecast period.

With the rise in Covid-19 cases, respiratory and remote monitoring are currently receiving more attention. Over the following two years, it is anticipated that this will further encourage market expansion. During the anticipated period, the market expansion is anticipated to be aided by the availability of new goods and the rising demands of emerging and undeveloped economies. Pulse oximetry is made mandatory for newborn screenings in around 43 states in the USA, and it is used to diagnose congenital heart disease (CHD) and other cardiovascular and respiratory diseases.

Among the most prevalent respiratory conditions worldwide are pneumonia, asthma, and chronic obstructive pulmonary disease (COPD). Low blood oxygen levels result from respiratory tract obstructions in COPD, asthma, and pneumonia, which make it challenging to exhale and exhale the lungs. Due to rising tobacco use and an aging population, the prevalence of COPD is anticipated to rise in the upcoming years. The incidence of COPD rises with age, especially in persons over the age of 45, according to the Australian Institute of Health and Welfare (AIHW). The mortality rate of COPD patients can be decreased with routine blood level monitoring. Additionally, pneumonia and acute respiratory distress syndrome (ARDS) are both directly related to COVID-19.

Pulse Oximeter helps in monitoring oxygen saturation over time, warning of dangerously low oxygen levels, especially in newborns, providing reassurance to those with long-term respiratory or cardiovascular conditions, determining the need for supplemental oxygen, checking oxygen saturation levels in anesthetized patients, and alerting the potentially harmful side effects in those taking medications that affect oxygen saturation or breathing.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which products can substitute Pulse Oximeter Market in Coming future?

A new home sleep apnea (HSAT) technology called WatchPAT uses a peripheral arterial signal (PAT) to identify the condition. It utilizes three contact points to measure seven channels, including the PAT signal, heart rate, oximetry, actigraphy, posture, snoring, and chest movements. After the research, raw data is retrieved in less than a minute and evaluated automatically to detect all varieties of apnea situations. AHI, AHic, RDI, and ODI are provided by WatchPAT based on Real Time Sleep and Sleep stages. The Home Sleep Test (HST) by WatchPAT has been clinically verified and has an 89% correlation with PSG1. The 2017 AASM Clinical Practice Guidelines recognize the PAT signal as technically adequate and include it.

Which Region is projected to Offer the Largest Pulse Oximeter Market Opportunity?

During the projection period, North America is expected to be the largest market. In terms of market share for pulse oximeters by 2020, the growth in the number of persons with impairments in the upcoming years and the ensuing rise in respiratory disorders accounted for a sizable portion of the North American market.

The availability of sophisticated healthcare infrastructure in the USA and Canada, as well as technological advancements in pulse oximeters significantly contribute to the expansion of the market in the area. The growth in market share of the region is also attributed to the well-developed infrastructure, adoption of pulse oximeters in households, rising incidence of chronic diseases and heart patients, and increase in healthcare spending.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

The USA Pulse Oximeter Market Analysis

The United States is expected to account for the highest market of US$ 2.2 billion by the end of 2032. It is expected to be projected to have an absolute dollar growth of US$ 1.1 billion. This is due to several factors such as an increase in the incidence of Chronic Diseases, increasing Covid-19 cases in the country, an increase in the geriatric population, and due to developed healthcare facilities. Around 43 states in the country have made it mandatory to use a pulse oximeter. The USA also has some of the key players in the market, which include Welch Allyn, Nonin medical, CAS Medical System Inc, Masimo, GE Healthcare, and Medtronic Plc.

The United Kingdom Pulse Oximeter Market Analysis

The market in The United Kingdom is expected to reach a valuation of US$ 234 million by 2032. With a CAGR of 9.2% from 2022 to 2032, the market is projected to grow at an absolute dollar opportunity of US$ 135 million.

Japan Pulse Oximeter Market Analysis

The market in Japan is expected to reach a valuation of US$ 167 million by 2032. With a CAGR of 9.4% from 2022 to 2032, the market is projected to grow at an absolute dollar opportunity of US$ 98.5 million.

South Korea Pulse Oximeter Market Analysis

The market in South Korea is expected to reach a valuation of US$ 90 million by 2032. With a CAGR of 8.6% from 2022 to 2032, the market is projected to grow at an absolute dollar opportunity of US$ 50.5 million.

Category-wise Insights

Why Hospital & other healthcare facility end-use is projected to Witness the Fastest Growth in Pulse Oximeter Market?

Market revenue through hospitals & other healthcare facility of the market is forecasted to grow at a CAGR of over 7.7% during 2022 to 32. Due to a growth in operations and emergency room visits, hospitals and other types of healthcare facilities held a commanding 82% market share for pulse oximeters by 2020.

For instance, a World Health Organization (WHO) survey found that more than 262 million people developed asthma in 2019 and that an estimated 4,61,000 individuals died as a result of medicines or subpar care. In order to continuously monitor the health of asthma patients, various nations are stressing the development of sophisticated pulse oximeters and spO2 monitoring devices in hospitals. One of the factors driving the adoption of pulse oximeters in hospitals is the expansion of patient options for quality care and accessibility in hospitals and clinics.

The availability of a variety of treatment choices, such as table-top or bedside pulse oximeters, increases patient acceptance and fuels market expansion. Hospitals also place a strong emphasis on giving the patient's family thorough training so they can use various pulse oximeters for routine check-ups. The business environment has also been substantially improved by the increased acceptance and release of low-cost, simple-to-use pulse oximeters for use in hospitals.

Competitive Analysis

The key companies in Pulse Oximeter Market are focused on alliances, technology collaborations, and product launch strategies. The Tier 2 Players in the market are targeting to increase their market share. Some of the recent developments of key Neural Implants providers are as follows:

  • In March 2022, the introduction of iPulseOx has been announced by Smart Meter, a manufacturer of patient monitoring equipment. The first cell phone-connected pulse oximeter offers remote patient monitoring services for long-term diseases like heart disease and chronic obstructive pulmonary disease (COPD). This product launch has improved the company's standing, giving them a competitive technological edge over its rivals and growing its customer base.
  • In June 2021, the release of the Oxy10 pulse oximeter was announced by DetelPro. The users of this product can determine the results with the aid of an LED display. The company's pulse oximeter portfolio was expanded throughout numerous hospitals and homecare facilities thanks to this product launch, which increased income for the company.
  • In February 2021, Masimo added enhanced measuring and patient monitoring capabilities by acquiring LiDCO, a provider of noninvasive and minimally invasive hemodynamic technology.
  • In January 2021, a fingertip pulse oximeter that links to the TytoCare device via a cable to log test results to patients' EHRs and enable remote monitoring by clinicians was introduced by the telehealth business Tyto Care.
  • In November 2020, in order to capitalize on the trend in digital health and ongoing investments in innovation, GE Healthcare increased its AI products and Edison ecosystem. The business is also introducing ground-breaking imaging technologies.
  • In May 2020, Masimo and Royal Philips reaffirmed their partnership, whereby Philips would incorporate extra Masimo measurement technologies into specific IntelliVue MX-series multiparameter monitors in order to aid doctors in determining cerebral oximetry and ventilation status.

Similarly, recent developments related to companies in Pulse Oximeter Market have been tracked by the team at Future Market Insights, which are available in the full report.

Pulse Oximeter Market Segmentation

By Type:

  • Fingertip
  • Handheld

By End-use:

  • Hospitals & Other Healthcare Facilities
  • Homecare

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much is the current worth of the Pulse Oximeter Market?

The global Pulse Oximeter Market is worth more than US$ 2.5 billion at present.

What is the sales forecast for Market?

The value of the Pulse Oximeter Market is projected to increase at a CAGR of around 7.6% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of the Pulse Oximeter Market increased at a CAGR of around 7.4% from 2017 to 2021.

What are the key Pulse Oximeter Market Trends?

The global demand for Pulse Oximeter Market is being fueled by an increase in awareness of people due to Covid-19, aging populations and due to the increase of chronic diseases Globally.

At what percentage is sales of Pulse Oximeter Market going to register growth in China?

The growth of the market for Pulse Oximeter in China is projected to expand at a CAGR of around 9.6% from 2022 to 2032.

At what percentage is sales of Pulse Oximeter Market going to register growth in United States?

The growth of the market for Pulse Oximeter in the United States is projected to expand at a CAGR of around 7.6% from 2022 to 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 8.6%, the market in Japan is projected to register a CAGR of nearly 9.4% from 2022 to 2032.

Table of Content

1. Executive Summary | Pulse Oximeter Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Type, 2022 to 2032

        5.3.1. Fingertip

        5.3.2. Handheld

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End-use, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End-use, 2022 to 2032

        6.3.1. Hospitals & Other Healthcare Facilities

        6.3.2. Homecare

    6.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2021

    7.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa (MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    8.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By End-use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By End-use

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Chile

            9.2.1.5. Peru

            9.2.1.6. Rest of Latin America

        9.2.2. By Type

        9.2.3. By End-use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By End-use

    9.4. Key Takeaways

10. Europe Pulse Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. The United Kingdom

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Type

        10.2.3. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End-use

    10.4. Key Takeaways

11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Type

        11.2.3. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End-use

    11.4. Key Takeaways

12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Type

        12.2.3. By End-use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End-use

    12.4. Key Takeaways

13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Type

        13.2.3. By End-use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By End-use

    13.4. Key Takeaways

14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC

            14.2.1.2. Rest of MEA

        14.2.2. By Type

        14.2.3. By End-use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By End-use

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. The USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Type

            15.1.2.2. By End-use

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Type

            15.2.2.2. By End-use

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Type

            15.3.2.2. By End-use

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Type

            15.4.2.2. By End-use

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Type

            15.5.2.2. By End-use

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Type

            15.6.2.2. By End-use

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Type

            15.7.2.2. By End-use

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Type

            15.8.2.2. By End-use

    15.9. The United Kingdom

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Type

            15.9.2.2. By End-use

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Type

            15.10.2.2. By End-use

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Type

            15.11.2.2. By End-use

    15.12. BENELUX

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Type

            15.12.2.2. By End-use

    15.13. China

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Type

            15.13.2.2. By End-use

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Type

            15.14.2.2. By End-use

    15.15. South Korea

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Type

            15.15.2.2. By End-use

    15.16. India

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Type

            15.16.2.2. By End-use

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Type

            15.17.2.2. By End-use

    15.18. Malaysia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Type

            15.18.2.2. By End-use

    15.19. Indonesia

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Type

            15.19.2.2. By End-use

    15.20. Australia

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Type

            15.20.2.2. By End-use

    15.21. New Zealand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Type

            15.21.2.2. By End-use

    15.22. GCC Countries

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Type

            15.22.2.2. By End-use

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By End-use

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Medtronic plc

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Carefusion Corp

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. GE Healthcare

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Philips Healthcare

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Masimo

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. CAS Medical Systems, Inc

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Opto Circuits India Ltd.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Nonin Medical, Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Meditech Equipment Co.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Welch Allyn

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Smart Pulse Oximeters Market

Published : December 2022

Packaging

Oxygen Indicator Labels Market

Published : July 2022

Healthcare

Oxygen Therapy Equipment Market

Published : June 2022

Explore Healthcare Insights

View Reports